65 results
8-K
EX-10.1
VANI
Vivani Medical Inc
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(mm) U.S. Real Property Holding Corporation. The Company
8-K
VANI
Vivani Medical Inc
10 Jan 24
Other Events
4:30pm
, Vivani Medical, Inc. (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq
8-K
v4m47zi6xqpgpp 6zz
27 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
DEFR14A
36qoftedrvn40bb3
1 May 23
Revised proxy
4:49pm
8-K
EX-10.1
l2ansuijj mn
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm
8-K
pmj 9e1v75x06
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
425
EX-99.1
r232o75xrz 35v
29 Jul 22
Business combination disclosure
9:07am
8-K
EX-99.1
v2vgvwdgxqfo
29 Jul 22
Submission of Matters to a Vote of Security Holders
9:05am
DEFA14A
oqoo6rjqmpevz0y
18 Jul 22
Additional proxy soliciting materials
8:47am
425
EX-99.1
q6v0 1p5uevzztar
18 Jul 22
Business combination disclosure
8:45am
8-K
EX-99.1
59ia0
18 Jul 22
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
8:44am
DEFM14A
bigk7ulwng
24 Jun 22
Proxy related to merger
4:44pm
424B3
za1xaj
24 Jun 22
Prospectus supplement
4:38pm
425
c67vsrnagwp8
21 Jun 22
Business combination disclosure
4:03pm